☆ 4.6 Letter

Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: Results of a prospective pilot study

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)

期刊

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

卷 71, 期 2, 页码 400-401

出版社

MOSBY-ELSEVIER

DOI: 10.1016/j.jaad.2014.04.028

关键词

-

类别

Dermatology

资金

NIAMS NIH HHS [R13 AR053058, T32 AR050942] Funding Source: Medline

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Pharmacology & Pharmacy

The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study

Yusi Chen, Jun Luo, Jingyuan Chen, Eugene Kotlyar, Zilu Li, Wenjie Chen, Jiang Li

Summary: The study on transitioning PAH patients from ambrisentan to macitentan showed successful and well-tolerated results, with improvements in exercise capacity, cardiac function, and hemodynamics. The transition was associated with greater efficacy and satisfaction.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Dermatology

Efficacy of adjunctive ambrisentan treatment for digital ulcers in patients with systemic sclerosis: a case series study

Bei Xu, Ye Yu, Junyu Liang, Guanhua Xu, Weiqian Chen, Jin Lin, Shenjiang Hu

Summary: Adjunctive ambrisentan therapy was effective in promoting DU healing and preventing new DUs in SSc patients.

JOURNAL OF DERMATOLOGICAL TREATMENT (2023)

添加到收藏夹

Article Medicine, General & Internal

Transition from Bosentan to Ambrisentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study

Jingyuan Chen, Jun Luo, Xiaojie Yang, Peng Luo, Yusi Chen, Zilu Li, Jiang Li

Summary: The study evaluated the safety, efficacy, and tolerability of transitioning stable PAH patients from bosentan to ambrisentan. Results showed no significant changes in biochemical markers, heart function, and quality of life over 6 months, indicating that ambrisentan is safe and well tolerated for this patient population.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis

Chiara Pellicano, Giorgia Leodori, Amalia Colalillo, Luca Navarini, Antonietta Gigante, Edoardo Rosato

Summary: The study found that serum resistin levels were significantly higher in systemic sclerosis (SSc) patients compared to healthy controls, but lower in patients with early capillaroscopic pattern. During a 52-week follow-up, about 48.6% of patients developed new digital ulcers (DUs), with those patients having significantly higher resistin levels. Increased serum resistin level was identified as a predictive marker for new DUs in SSc patients.

CLINICAL AND EXPERIMENTAL MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis

Zhanying Hou, Xuehan Su, Guangming Han, Ruzeng Xue, Yangxia Chen, Ye Chen, Huan Wang, Bin Yang, Yunsheng Liang, Suyun Ji

Summary: This study found that JAK1 and JAK2 inhibitors have significant efficacy in alleviating skin fibrosis and digital ulcers in systemic sclerosis (SSc) patients. Baricitinib, an oral JAK1/2 inhibitor, is a potentially effective treatment for SSc patients with skin fibrosis and ulcers, with good tolerability. Further large-scale clinical trials are needed to confirm these preliminary findings.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Study Protocol: A Randomized Controlled Prospective Single-Center Feasibility Study of Rheopheresis for Raynaud's Syndrome and Digital Ulcers in Systemic Sclerosis (RHEACT Study)

Jan-Gerd Rademacher, Bjoern Tampe, Angela Borisch, Rosa Marie Buschfort, Andrea Von Figura, Thomas Asendorf, Peter Korsten

Summary: This study aims to investigate the efficacy of RheoP on Raynaud's syndrome and Digital Ulcers in Systemic Sclerosis (SSc) patients. The primary outcome measure is the Raynaud Condition Score (RCS) after 16 weeks. The study will include 30 patients randomized to either RheoP treatment groups or a standard treatment control group. Secondary endpoints include changes in DU, nailfold video capillaroscopy, and patient-reported outcomes.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Review Medicine, General & Internal

Iloprost Duration for Digital Ulcers in Systemic Sclerosis: French Retrospective Study at Two Centers and Literature Review

Celine Jamart, Herve Levesque, Sara Thietart, Olivier Fain, Sebastien Riviere, Ygal Benhamou, Arsene Mekinian

Summary: The study aimed to investigate whether prolonging the infusion duration of iloprost beyond 5 days could improve the healing rate of SSc-related DUs. The results suggest that extending the iloprost infusion period beyond 5 days can increase the healing rate and time of SSc-related DUs.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Rheumatology

The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort study

Laura Ross, Dylan Hansen, Nancy Maltez, Kathleen Morrisroe, Kimti Kumar, Jennifer Walker, Wendy Stevens, Joanne Sahhar, Gene-Siew Ngian, Lauren Host, Mandana Nikpour, Susanna Proudman

Summary: This study found that calcium channel blockers (CCB) are frequently used in the management of systemic sclerosis (SSc) and are associated with severe peripheral vascular manifestations of SSc. However, CCB may not be effective in the healing or prevention of digital ulcers (DU).

CLINICAL RHEUMATOLOGY (2023)

添加到收藏夹

Article Peripheral Vascular Disease

Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients

Chiara Pellicano, Laura Romaggioli, Marzia Miglionico, Amalia Colalillo, Cesarina Ramaccini, Antonietta Gigante, Maurizio Muscaritoli, Edoardo Rosato

Summary: This study evaluated the serum levels of MaR1 in SSc patients and healthy controls, and found that MaR1 levels were significantly lower in SSc patients. In multivariate analysis, a serum level of MaR1 > 393.2 pg/ml was identified as a predictive marker for new digital ulcers.

MICROVASCULAR RESEARCH (2022)

添加到收藏夹

Review Rheumatology

Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives

Ioannis Sagonas, Dimitrios Daoussis

Summary: Digital ulcers are the main manifestation of vasculopathy in systemic sclerosis patients and a major cause of disability. Recent research has shown that prostacyclin analogues, endothelin antagonists, and phosphodiesterase 5 inhibitors have promising results in treating and preventing digital ulcers. Autologous fat grafting and botulinum toxin injections can also be useful in stubborn cases. However, challenges remain and better-designed trials are needed to optimize treatment.

CLINICAL RHEUMATOLOGY (2023)

添加到收藏夹

Review Medicine, General & Internal

Digital Ulcers in Systemic Sclerosis

Michael Hughes, Cosimo Bruni, Barbara Ruaro, Marco Confalonieri, Marco Matucci-Cerinic, Silvia Bellando-Randone

Summary: Digital ulcers are a common complication of Systemic Sclerosis-related vasculopathy, posing a significant burden for patients and society. Treatment of DU requires a multidisciplinary team and patient education, with several drugs currently available for management. Further research is needed to improve approaches and therapies for DU in the future.

PRESSE MEDICALE (2021)

添加到收藏夹

Review Rheumatology

Surgical management of digital ulcers in systemic sclerosis: A systematic literature review

Yossra A. Suliman, Corrado Campochiaro, Michael Hughes, Jan W. Schoones, Dilia Giuggioli, Pia Moinzadeh, Murray Baron, Lorinda Chung, Laura Ross, Nancy Maltez, Yannick Allanore, Christopher P. Denton, Oliver Distler, Tracy Frech, Daniel E. Furst, Dinesh Khanna, Thomas Krieg, Masataka Kuwana, Marco Matucci-Cerinic, Janet Pope, Alessia Alunno

Summary: This study examined the safety and efficacy of local surgical management for digital ulcers (DUs) in patients with systemic sclerosis (SSc). The results showed that several surgical approaches, including autologous fat grafting, autologous adipose-derived stromal vascular fraction grafting, and bone marrow derived cell transplantation, demonstrated some degree of safety and effectiveness for DU healing in SSc-DU patients.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2023)

添加到收藏夹

Article Peripheral Vascular Disease

Color Doppler Ultrasonography of digital arteries and digital ulcers development in systemic sclerosis

Amalia Colalillo, Valentina Vaiarello, Chiara Pellicano, Giorgia Leodori, Antonietta Gigante, Edoardo Rosato

Summary: The study evaluated the role of Color Doppler Ultrasonography of proper palmar digital arteries as a predictive marker for new digital ulcers in SSc patients over a 5-year follow-up. The results showed that RI of PPDA in association with NVC could be used to assess SSc patients at increased risk of new DUs development.

MICROVASCULAR RESEARCH (2021)

添加到收藏夹

Article Rheumatology

Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology

D. Temiz Karadag, Y. Yalcinkaya, A. Akdogan, A. Avanoglu, C. Bes, A. M. Birlik, A. Cefle, M. Erdogan, G. Hatemi, O. C. Icacan, M. Inanc, N. Inanc, S. S. Koca, O. Kucuksahin, M. Ozgen, A. Sari, A. Sahin, S. Senel, A. Tufan, S. Ugurlu, F. Yargucu Zihni, S. Yolbas, V Hamuryudan

Summary: This study has developed evidence-based recommendations for the management of SSc-associated DUs, aiming to provide a useful guide to all physicians involved in the care of patients with SSc and highlighting unmet needs in this field.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis

Sung Hae Chang, Jae Bum Jun, Yun Jong Lee, Tae Young Kang, Ki Won Moon, Ji Hyeon Ju, Seong Wook Kang, In Ah Choi, Yong-Beom Park, Seung Geun Lee, Shin-Seok Lee, Nam Hun Heo, Eun Bong Lee

Summary: The study evaluated the efficacy of ERA and PDE5i in treating SSc-related digital ulcers and found that both are comparable in terms of time to ulcer healing, but ERA is more effective in reducing the occurrence of new DUs.

RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Cessation of Immunomodulatory Medication Use in Dermatomyositis: A Single-Center Cohort Study

Sung Kyung Cho, Livia Casciola-Rosen, Puneet Kapoor, Lorinda Chung, David Fiorentino

Summary: The frequency of discontinuing systemic immunomodulatory therapy in adults with dermatomyositis (DM) and the factors associated with medication cessation were evaluated. A cohort of adult DM patients seen in a rheumatology/dermatology clinic between 2013 and 2020 was studied, and it was found that approximately 20% of the patients discontinued all immunomodulatory medications. Patients with clinically amyopathic disease, anti-MDA5, anti-NXP2, and anti-SAE1 antibodies were more likely to cease medication.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Rheumatology

Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease

David Roofeh, Kevin K. Brown, Ella A. Kazerooni, Donald Tashkin, Shervin Assassi, Fernando Martinez, Athol U. Wells, Ganesh Raghu, Christopher P. Denton, Lorinda Chung, Anna-Maria Hoffmann-Vold, Oliver Distler, Kerri A. Johannson, Yannick Allanore, Eric L. Matteson, Leticia Kawano-Dourado, John D. Pauling, James R. Seibold, Elizabeth R. Volkmann, Simon L. F. Walsh, Chester Oddis, Eric S. White, Shaney L. Barratt, Elana J. Bernstein, Robyn T. Domsic, Paul F. Dellaripa, Richard Conway, Ivan Rosas, Nitin Bhatt, Vivien Hsu, Francesca Ingegnoli, Bashar Kahaleh, Puneet Garcha, Nishant Gupta, Surabhi Khanna, Peter Korsten, Celia Lin, Stephen C. Mathai, Vibeke Strand, Tracy J. Doyle, Virginia Steen, Donald F. Zoz, Juan Ovalles-Bonilla, Ignasi Rodriguez-Pinto, Padmanabha D. Shenoy, Andrew Lewandoski, Elizabeth Belloli, Alain Lescoat, Vivek Nagaraja, Wen Ye, Suiyuan Huang, Toby Maher, Dinesh Khanna

Summary: This study aimed to establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD). The results showed that using the proposed conceptual framework, international experts were able to achieve a consensus on classifying SSc-ILD patients along the dimensions of disease severity, risk of progression and progression over time.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin

Monica Yang, Vivien Goh, Jungwha Lee, Monica Espinoza, Yiwei Yuan, Mary Carns, Kathleen Aren, Lorinda Chung, Dinesh Khanna, Zsuzsanna H. McMahan, Rishi Agrawal, Lauren Beussink Nelson, Sanjiv J. Shah, Michael L. Whitfield, Monique Hinchcliff

Summary: The classification of systemic sclerosis (SSc) patients based on skin gene expression can identify different clinical phenotypes and provide additional clinically useful information to current SSc classification systems.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Rheumatology

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation

Burcu Ayoglu, Michele Donato, Daniel E. Furst, Leslie J. Crofford, Ellen Goldmuntz, Lynette Keyes-Elstein, Judith James, Susan Macwana, Maureen D. Mayes, Peter McSweeney, Richard A. Nash, Keith M. Sullivan, Beverly Welch, Ashley Pinckney, Rong Mao, Lorinda Chung, Purvesh Khatri, Paul J. Utz

Summary: Results from the SCOT clinical trial showed that HSCT had significant benefits over CTX in patients with systemic sclerosis. The objective of this study was to test the hypothesis that transplantation stabilizes the autoantibody repertoire in patients with favorable clinical outcomes. Analysis of autoantibody profiles revealed significant differences between HSCT and CTX-treated patients, suggesting that HSCT alters the autoantibody repertoire while CTX treatment does not.

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Article Rheumatology

Patient Experience of Systemic Sclerosis-Related Calcinosis An International Study Informing Clinical Trials, Practice, and the Development of the Mawdsley Calcinosis Questionnaire

Lesley Ann Saketkoo, Jessica K. Gordon, Kim Fligelstone, Anne Mawdsley, Humza A. Chaudhry, Antonia Valenzuela, Angela Christensen, Samara M. Khalique, Kelly Jensen, Sophia C. Weinmann, Evan Busman, Lorinda Chung, Vivien M. Hsu, Anne-Marie Russell, Virginia D. Steen

Summary: The patient experience of SSc-calcinosis was analyzed in an international cohort, leading to a better understanding of the pervasive disability, frustration, symptom distress, and uncertainty associated with daily living with the condition. Patient observations and self-management behavior offer opportunities for education of clinicians and patients, with a need for self-management guidance. The findings informed the development of a novel PROM, the MCQ, for assessing the severity and impact of SSc-calcinosis in clinical studies and practice.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2023)

添加到收藏夹

Article Rheumatology

Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles

Didem Saygin, Hanna Kim, Christian Douglas, Brian Erman, Jesse Wilkerson, John A. McGrath, Chester Oddis, Ingrid E. Lundberg, Anthony A. Amato, Ignacio Garcia-De La Torre, Hector Chinoy, David Fiorentino, Lorinda Chung, Yeong-Wook Song, Frederick W. Miller, Nicolino Ruperto, Jiri Vencovsky, Rohit Aggarwal, Lisa G. Rider

Summary: This study further validated the ACR-EULAR Myositis Response Criteria (MRC) by assessing the contribution of each core set measure, the frequency of improvement in strength vs extramuscular activity, the representation of patient-reported outcome measures (PROM), and the frequency of core set measure worsening. The results showed that improvement in strength was the main contributing factor, and the majority of patients also had improvement in PROM.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization

Sarah Luebker, Tracy M. Frech, Shervin Assassi, Brian Skaug, Jessica K. Gordon, Kimberly Lakin, Elana J. Bernstein, Yiming Luo, Virginia D. Steen, Ami A. Shah, Laura K. Hummers, Carrie Richardson, Duncan F. Moore, Dinesh Khanna, Flavia Castelino, Lorinda Chung, Puneet Kapoor, Faye N. Hant, Victoria K. Shanmugam, John M. VanBuren, Jessica Alvey, Monica Harding, Ankoor Shah, Ashima Makol, Dorota Lebiedz-Odrobina, Julie K. Thomas, Elizabeth R. Volkmann, Jerry A. Molitor, Nora Sandorfi

Summary: The study conducted by the CONQUER collaborative revealed that severe gastrointestinal symptoms in SSc patients lead to increased healthcare resource utilization. Understanding the pattern of resource utilization, especially in early disease stages, is crucial for managing the health-related costs of SSc.

RHEUMATOLOGY (2023)

添加到收藏夹

Review Rheumatology

Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review

Laura Ross, Nancy Maltez, Michael Hughes, Jan W. Schoones, Murray Baron, Lorinda Chung, Dilia Giuggioli, Pia Moinzadeh, Yossra A. Suliman, Corrado Campochiaro, Yannick Allanore, Christopher P. Denton, Oliver Distler, Tracy Frech, Daniel E. Furst, Dinesh Khanna, Thomas Krieg, Masataka Kuwana, Marco Matucci-Cerinic, Janet Pope, Alessia Alunno

Summary: A systematic literature review found that intravenous iloprost, phosphodiesterase-5 inhibitors, and atorvastatin are effective for the treatment of SSc digital ulcers. Bosentan can reduce the occurrence of future ulcers. Limited evidence supports the effectiveness of Janus kinase inhibitors, while immunosuppression or anti-platelet agents have insufficient data to support their use. Further research is needed to define the optimal treatment regimen.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Dermatology

Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis

Paula Song, Shufeng Li, Matthew A. Lewis, David F. Fiorentino, Lorinda Chung

Summary: Degos-like lesions are associated with diffuse cutaneous systemic sclerosis (SSc) and other cutaneous manifestations of vasculopathy, including acro-osteolysis, calcinosis, and digital ulcers.

JAMA DERMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis

Robyn T. Domsic, Robin Pokrzywinski, Larissa Stassek, Wade W. Benton, Christa-Lynn Vampola, Daniel E. Furst, Lorinda Chung, Virginia Steen, Maureen D. Mayes, Ami A. Shah, Jerry A. Molitor, Kelly Oliver, Vivek Nagaraja, Dinesh Khanna

Summary: The study aimed to understand the symptoms and impacts of Raynaud phenomenon (RP) in patients with systemic sclerosis (SSc) and evaluate the content validity and usability of the Raynaud Diary, a new electronic patient-reported outcome (PRO) measure for RP. Participants reported frequent RP symptoms such as color change, numbness, tingling, pain, and discomfort. Common triggers for RP attacks included temperature-related factors and stress. The participants demonstrated understanding of the Raynaud Diary instructions and indicated that they could use it to record the worst severity of individual RP symptoms.

ACR OPEN RHEUMATOLOGY (2023)

添加到收藏夹

Editorial Material Rheumatology

Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis

Lesley Ann Saketkoo, Antonia Valenzuela, Susan Kim, Liza J. McCann, Christian Lood, Dawn M. Wahezi, Victoria P. Werth, Belina Yi, Helene Alexanderson, Susan Maillard, Clarissa Pilkington, Kim Fligelstone, Barbara Limbach, Amir B. Orandi, Malin Regardt, Anne-Marie Russell, Srijana Davuluri, Ingrid deGroot, Floranne Ernste, Julie J. Paik, Carlos A. von Muhlen, Mazen M. Dimachkie, Pedro M. Machado, Elie Naddaf, Barbara M. Shafranski, Latika Gupta, Francesco Zulian, Lorinda Chung

RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Endothelial Biomarkers of Systemic Sclerosis-Associated Pulmonary Hypertension

Matthew R. Lammi, Kathleen D. Kolstad, Lesley Ann Saketkoo, Avani Khatri, Paul J. Utz, Virginia D. Steen, Lorinda Chung

Summary: The study shows that certain endothelial biomarkers (ADMA, sEng, and PTX-3) can determine the risk of SSc-PH and differentiate between SSc-PH subgroups. PTX-3 is a promising biomarker for PH risk and a possible marker for precapillary PH, but ADMA and sEng do not show significant differences in this regard.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Rheumatology

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

Robert Spiera, Masataka Kuwana, Dinesh Khanna, Laura M. Hummers, Tracy Frech, Wendy Stevens, Marco Matucci-Cerinic, Suzanne Kafaja, Oliver Distler, Jae-Bum Jun, Yair Levy, Piotr Leszcyznski, Jessica Gordon, Virginia Steen, Eun Bong Lee, Tomasz Jankowski, Irena Litinsky, Lorina Chung, Vivien Hsu, Maureen Mayes, Nora W. Sandorfi, Robert Simms, Stephanie Finzel, Jeska de Vries-Bouwstra, Scott Constantine, Nancy Dgetluck, Quinn J. Dinh, Bradley E. Bloom, Daniel Furst, Barbara P. White, Christopher Denton

Summary: The efficacy and safety of lenabasum in dcSSc patients were investigated. The study failed to demonstrate a benefit of lenabasum in dcSSc, but showed better outcomes in patients treated with background IST, particularly mycophenolate mofetil.

ARTHRITIS & RHEUMATOLOGY (2023)

添加到收藏夹

Article Respiratory System

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

Franck F. Rahaghi, Vivien M. Hsu, Robert J. Kaner, Maureen D. Mayes, Ivan O. Rosas, Rajan Saggar, Virginia D. Steen, Mary E. Strek, Elana J. Bernstein, Nitin Bhatt, Flavia V. Castelino, Lorinda Chung, Robyn T. Domsic, Kevin R. Flaherty, Nishant Gupta, Bashar Kahaleh, Fernando J. Martinez, Lee E. Morrow, Teng Moua, Nina Patel, Oksana A. Shlobin, Brian D. Southern, Elizabeth R. Volkmann, Dinesh Khanna

Summary: This study aimed to develop consensus recommendations on the management of patients with SSc-ILD based on expert physician insights. A modified Delphi process was completed by pulmonologists and rheumatologists, resulting in the generation of a management algorithm that addresses the current gaps in management approaches.

RESPIRATORY RESEARCH (2023)

添加到收藏夹

Article Rheumatology

Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States

Yumeko Kawano, Kathleen D. Kolstad, Shufeng Li, Julia F. Simard, Lorinda Chung

Summary: Over the past 18 years, there has been a significant reduction in fetal death risk among women with SSc, but the risk for other adverse pregnancy outcomes remains higher in SSc deliveries compared to non-SSc deliveries.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.